BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2408983)

  • 1. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
    Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
    Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
    Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
    Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steatorrhea and its treatment with pancreatic enzymes in endocrine tumors of the pancreas (pancreatic adenomas)].
    Varas MJ; López A
    Rev Esp Enferm Dig; 1990 Jul; 78(1):27-30. PubMed ID: 1701657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of pancreatic insufficiency with a preparation containing high lipase activity].
    Pap A; Szilágyi V; Marosi E
    Orv Hetil; 1997 Mar; 138(10):601-4. PubMed ID: 9157336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pancreatic enzyme replacement in mucoviscidosis (CF): clinical evaluation of a gastric acid-resistant pancreatin preparation in encapsulated microtablet form].
    Stern M; Plettner C; Grüttner R
    Klin Padiatr; 1988; 200(1):36-9. PubMed ID: 2452915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
    Griffin SM; Alderson D; Farndon JR
    Gut; 1989 Jul; 30(7):1012-5. PubMed ID: 2759481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
    Lankisch PG
    Digestion; 1993; 54 Suppl 2():21-9. PubMed ID: 8224569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
    Pap A; Varró V
    Hepatogastroenterology; 1988 Apr; 35(2):83-6. PubMed ID: 3371850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL
    Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I; Kubias K; Duda M
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():21-3. PubMed ID: 7526630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery].
    Farkas G; Leindler L; Mihalovits G
    Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theory and practice in the individualization of oral pancreatic enzyme administration for chronic pancreatitis.
    Andrén-Sandberg A
    Int J Pancreatol; 1989; 5 Suppl():51-62. PubMed ID: 2702251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.